- Home
- AKRO vs HEES Comparison
AKRO vs HEES Comparison
Compare AKRO & HEES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- HEES
- Stock Information
- Founded
- AKRO 2017
- HEES 1961
- Country
- AKRO United States
- HEES United States
- Employees
- AKRO N/A
- HEES N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- HEES Misc Corporate Leasing Services
- Sector
- AKRO Health Care
- HEES Industrials
- Exchange
- AKRO Nasdaq
- HEES Nasdaq
- Market Cap
- AKRO 2.0B
- HEES 1.8B
- IPO Year
- AKRO 2019
- HEES 2006
- Fundamental
- Price
- AKRO $25.14
- HEES $88.12
- Analyst Decision
- AKRO Strong Buy
- HEES Buy
- Analyst Count
- AKRO 8
- HEES 6
- Target Price
- AKRO $46.83
- HEES $69.25
- AVG Volume (30 Days)
- AKRO 807.7K
- HEES 1.2M
- Earning Date
- AKRO 02-27-2025
- HEES 02-20-2025
- Dividend Yield
- AKRO N/A
- HEES 1.24%
- EPS Growth
- AKRO N/A
- HEES N/A
- EPS
- AKRO N/A
- HEES 3.94
- Revenue
- AKRO N/A
- HEES $1,518,307,000.00
- Revenue This Year
- AKRO N/A
- HEES $4.55
- Revenue Next Year
- AKRO N/A
- HEES $3.91
- P/E Ratio
- AKRO N/A
- HEES $22.38
- Revenue Growth
- AKRO N/A
- HEES 5.69
- 52 Week Low
- AKRO $15.32
- HEES $40.92
- 52 Week High
- AKRO $37.00
- HEES $90.66
- Technical
- Relative Strength Index (RSI)
- AKRO 41.89
- HEES 81.18
- Support Level
- AKRO $21.34
- HEES $87.70
- Resistance Level
- AKRO $28.94
- HEES $90.66
- Average True Range (ATR)
- AKRO 1.38
- HEES 1.37
- MACD
- AKRO -0.27
- HEES 5.21
- Stochastic Oscillator
- AKRO 49.67
- HEES 94.64
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
About HEES H&E Equipment Services Inc.
H&E Equipment Services Inc is an integrated equipment services company. It is focused on heavy construction and industrial equipment. It rents, sells, and provides parts and services support for four core categories of equipment including hi-lift or aerial work platform equipment, cranes, earthmoving equipment, and industrial lift trucks. It engages in five principal business activities: equipment rentals; new equipment sales; sales of rental equipment; parts sales; and services. The majority of its revenue is derived from the equipment rentals segment.